Results 241 to 250 of about 92,879 (297)
Some of the next articles are maybe not open access.
Vaccines to Prevent Viral Hepatitis
New England Journal of Medicine, 1997At least five different viruses cause hepatitis in humans. Two — hepatitis A virus (HAV) and hepatitis E virus (HEV) — are nonenveloped RNA viruses that are spread predominantly by fecal–oral transmission and cause acute self-limited disease.1,2 The others — hepatitis B virus (HBV), hepatitis delta virus (HDV), and hepatitis C virus (HCV) — are ...
S M, Lemon, D L, Thomas
openaire +2 more sources
Vaccines for prevention of viral hepatitis
Haemophilia, 1998Summary. At the end of the 20th century active immunization against hepatitis A and B has been introduced into routine medical practice. Therefore, patients at risk, and especially those with coagulation disorders, should be immunized at the earliest age possible.
C. A. Lee +5 more
openaire +2 more sources
2011
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire +1 more source
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire +1 more source
Viral hepatitis: Global goals for vaccination
Journal of Clinical Virology, 2012In countries where hepatitis A is highly endemic, exposure to hepatitis A virus (HAV) is almost universal before the age of 10 years, and large-scale immunization efforts are not required. In contrast, in areas of intermediate endemicity or in transition from high to intermediate endemicity, where transmission occurs primarily from person to person in ...
openaire +2 more sources
Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection
Vaccine, 1997Patients on hemodialysis therapy are at a relatively high risk of exposure to hepatitis B virus (HBV) infection. The prevalence of hepatitis C virus (HCV) infection is even higher and was reported as 33.2% in Taiwan. Although the efficacy of hepatitis B vaccine was well documented, the vaccination schedule in hemodialysis patients is not clearly ...
C H, Cheng +5 more
openaire +2 more sources
WITHDRAWN: Viral Hepatitis: global goals for vaccination
Journal of Clinical Virology, 2009This article has been withdrawn at the request of the author. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
openaire +2 more sources
Current Diabetes Reports, 2016
Viral hepatitis has been posited to play a role in the development of type 2 diabetes. Thus, prevention of viral hepatitis through vaccination has the potential to reduce the burden of type 2 diabetes. We have shown that successful hepatitis B vaccination reduces the risk of diabetes by 33 %.
Rudruidee, Karnchanasorn +4 more
openaire +2 more sources
Viral hepatitis has been posited to play a role in the development of type 2 diabetes. Thus, prevention of viral hepatitis through vaccination has the potential to reduce the burden of type 2 diabetes. We have shown that successful hepatitis B vaccination reduces the risk of diabetes by 33 %.
Rudruidee, Karnchanasorn +4 more
openaire +2 more sources
Antigen-Antibody Complex as Therapeutic Vaccine for Viral Hepatitis B
International Reviews of Immunology, 1999In a previous study, hepatitis B surface antigen (HBsAg) complexed to human anti-HBs immunoglobulins (HBIG) in excess of HBsAg was used as therapeutic vaccine to treat chronic hepatitis B patients and promising results were obtained. To study the mechanisms of this approach, mice were immunized with HBsAg or IC (immunogenic complex, i.e.
Y M, Wen, D, Qu, S H, Zhou
openaire +2 more sources
An inactivated hepatitis A viral vaccine of cell culture origin
Journal of Medical Virology, 1986AbstractHepatitis A virus (HAV) strain CR326, adapted to grow in LLC‐MK2 cells, was highly purified, inactivated with formalin, adsorbed to alum, and tested for capacity to induce antibody to HAV in both mice and marmosets. The minimum dose of HAV antigen necessary to produce antibody in 50% of mice was 10 ng.
P J, Provost +5 more
openaire +2 more sources
Post-exposure hepatitis B vaccination of sexual partners of acute viral hepatitis patients
Journal of Infection, 1983Sexual transmission of HBV was studied in a sample of 350 sporadic acute viral hepatitis type B adult patients hospitalised in the Infectious Diseases Hospital of Athens, Greece. Spouses with acute viral hepatitis type B (six in number) or asymptomatic HBsAg carriership (80 in number) were considered as the most likely sources of infection in 86 (24.6 ...
G, Papaevangelou +5 more
openaire +2 more sources

